July 2017 FDA Recall Drug by Chiavna Saffron Llc
D-1145-2017 - Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil
This Class I drug recall was voluntarily initiated by Chiavna Saffron Llc on July 21, 2017 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda;fda analysis found product to be tainted with sildendafil and tadalafil. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1145-2017
Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil
07-21-2017
09-20-2017
211 bottles; 339 boxes
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Chiavna Saffron LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Press Release
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
03-27-2018
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY
Batch or Lot Expiration Information
Lot# a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020